Evidence map›Paper›PMID 36935687›Full record

Trial reportFrontiers in public health2023

Development and validation of nomogram including high altitude as a risk factor for COPD: A cross-sectional study based on Gansu population.

Ao Lin, Chun Mao, Boqi Rao, Hongjun Zhao, Yunchao Wang, Guokang Yang, Haisheng Lei, Chenli Xie, Dongsheng Huang, Yibin Deng and 3 more

Open access · goldFull text readRandomized Controlled Trial
In one paragraph

Trial report in Frontiers in public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 1 country.

Ao LinThe State Key Lab of Respiratory Disease, The First Affiliated Hospital, Institute of Public Health, Guangzhou Medical University, Guangzhou, China.
Chun MaoThe State Key Lab of Respiratory Disease, The First Affiliated Hospital, Institute of Public Health, Guangzhou Medical University, Guangzhou, China.
Boqi RaoThe State Key Lab of Respiratory Disease, The First Affiliated Hospital, Institute of Public Health, Guangzhou Medical University, Guangzhou, China.
Hongjun ZhaoDepartment of Pulmonary and Critical Care Medicine, Quzhou People's Hospital, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou, China.
Yunchao WangInstitute of Basic Medicine, Institute of Public Health, Gansu University of Chinese Medicine, Lanzhou, China.
Guokang YangInstitute of Basic Medicine, Institute of Public Health, Gansu University of Chinese Medicine, Lanzhou, China.
Haisheng LeiInstitute of Basic Medicine, Institute of Public Health, Gansu University of Chinese Medicine, Lanzhou, China.
Chenli XieDepartment of Respiratory and Critical Care Medicine, Dongguan Binwan Central Hospital, Dongguan, China.
Dongsheng HuangDepartment of Respiratory and Critical Care Medicine, Shenzhen Longhua District Central Hospital, Shenzhen, China.
Yibin DengCentre for Medical Laboratory Science, The Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.
Xuhui ZhangDepartment of Respiratory Medicine, The Affiliated Hospital of Gansu University of Chinese Medicine, Lanzhou, China.
Xinhua WangInstitute of Basic Medicine, Institute of Public Health, Gansu University of Chinese Medicine, Lanzhou, China.
Jiachun LuThe State Key Lab of Respiratory Disease, The First Affiliated Hospital, Institute of Public Health, Guangzhou Medical University, Guangzhou, China.
Gansu University of Traditional Chinese Medicine · CNFirst Affiliated Hospital of Guangzhou Medical University · CNGuangzhou Medical University · CNAffiliated Hospital of Youjiang Medical University for Nationalities · CNDongguan People’s Hospital · CNLonggang Central Hospital · CNWenzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Chronic Obstructive Pulmonary Disease (COPD) is a common and harmful disease that requires an effective tool to early screen high-risk individuals. Gansu has unique environments and customs, leading to the different prevalence and etiology of COPD from other regions. The association between altitude and COPD once attracted epidemiologists' attention. However, the prevalence in Gansu and the role of altitude are still unclarified. Methods: In Gansu, a multistage stratified cluster sampling procedure was utilized to select a representative sample aged 40 years or older. The questionnaire and spirometry examination were implemented to collect participants' information. The diagnosis and assessment of COPD were identified by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criterion, while post-bronchodilator FEV Results: There were 2,486 eligible participants in the final analysis, of which 1,584 lived in low altitudes and 902 lived in high altitudes. Based on the GOLD criterion, the crude and standardized prevalences in Gansu were 20.4% (18.7-22.0) and 19.7% (17.9-21.6). After PSM, the logistic regression model indicated that high altitude increased COPD risk [PSM OR: 1.516 (1.162-1.978)]. Altitude, age, sex, history of tuberculosis, coal as fuel, and smoking status were reserved for developing a nomogram that demonstrated excellent discrimination, calibration, and clinical benefit in the two sets. Conclusions: COPD has become a serious public health problem in Gansu. High altitude is a risk factor for COPD. The nomogram has satisfactory efficiency in screening high-risk individuals.

Indexed as

AltitudePulmonary Disease, Chronic ObstructiveCross-Sectional StudiesHumansNomogramsRisk FactorsSmokingaltitudeCOPDnomogramprevalencerisk factor

Identifiers

PMID36935687
PMCPMC10019355
OpenAlexW4322767801

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read213
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.